The Veterans Day holiday kept volumes down on Monday and
benchmarks added meager gains during a mostly uneventful trading
session. However, the gains were sufficient for the Dow to clinch
another record high, the thirty fifth such instance this year.
Among the S&P 500 industry groups, health care stocks gained
the most, whereas the consumer staples sector incurred huge
For a look at the issues currently facing the markets, make sure
to read today's
Ahead of Wall Street
The Dow Jones Industrial Average (DJI) climbed 0.1% to close the
day at 15,783.10. The S&P 500 rose 0.1% to finish yesterday's
trading session at 1,771.89. The tech-laden Nasdaq Composite
Index gained 0.01% to end at 3,919.79. The fear-gauge CBOE
Volatility Index (VIX) dropped 2.9% to settle at 12.53.
Consolidated volumes on the New York Stock Exchange were roughly
2.54 billion shares. Advancing stocks outnumbered the decliners.
For 50% shares that advanced, only 46% declined.
Stocks moved moderately higher on Monday during a thinly traded
session owing to the Veterans Day holiday. Nonetheless, the Dow
rallied toward a record high for the third time in the month, and
the thirty fifth time this year. Such gains are primarily
attributable to an encouraging jobs report. Investors now believe
that the economy's has gained sufficient strength to withstand
the Federal Reserve's tapering of its stimulus program. Such a
move is expected to happen as soon as December.
Apart from yesterday's session being low on volumes, there was
little news which could impact the benchmarks' movement. Among
the few developments, Viropharma Inc. (NASDAQ:
) shares jumped 25.5 % to $49.41, following news that Shire PLC
will purchase the company for $4.2 billion.
Shares of Transocean Ltd. (NYSE:
) gained 3.8% to touch $55.49 per share, after the company
announced it had reached an agreement with investor Carl Icahn to
pay a dividend of $3 per share. The offshore driller has also
reached an agreement with Icahn to reduce the size of its board.
Jobs data published on Friday showed that 204,000 jobs were
created in October, better than the consensus estimate of 114,000
jobs. The report led investors to believe that the Federal
Reserve would reduce its level of bond purchases by next month
Supporting the above expectations are last week's comments from
members of the central bank who said the Federal Reserve should
reduce its asset purchases only when it receives clear
indications that the economy is improving. However, the three Fed
officials did not comment on exactly when they believe the
stimulus program should be withdrawn.
Twitter Inc. (NYSE:
) which made its debut in the stock market on Thursday last week,
dropped marginally, by 0.05% to end yesterday's trading day at
$41.63 per share. The company ended Thursday trading session at
$44.90, a 73% jump from its $26 initial public offering (IPO)
price. Prices had increased to more than $50 during the trading
Coming back to yesterday's session, the healthcare sector was the
biggest gainer among the S&P 500 industry groups and the
Health Care SPDR (XLV) gained 0.24%. Stocks such as Johnson &
), Merck & Co., Inc. (NYSE:
), Gilead Sciences, Inc. (NASDAQ:
), Bristol-Myers Squibb Co (NYSE:
), and AbbVie Inc. (NYSE:
) added 0.3%, 0.4%, 0.2%, 0.4%, and 1.1%, respectively.
Consumer staples were the biggest loser among the S&P 500
industry groups as the Consumer Staples SPDR (XLP) lost 0.3%.
Stocks such as The Procter & Gamble Company (NYSE:
), The Coca-Cola Company (NYSE:
), PepsiCo, Inc. (NYSE:
), Altria Group Inc. (NYSE:
), and Colgate-Palmolive Company (NYSE:
) slipped 0.3%, 0.5%, 0.5%, 0.3%, and 0.3%, respectively.
ABBVIE INC (ABBV): Free Stock Analysis Report
BRISTOL-MYERS (BMY): Free Stock Analysis
COLGATE PALMOLI (CL): Free Stock Analysis
GILEAD SCIENCES (GILD): Free Stock Analysis
JOHNSON & JOHNS (JNJ): Free Stock Analysis
COCA COLA CO (KO): Free Stock Analysis Report
ALTRIA GROUP (MO): Free Stock Analysis Report
MERCK & CO INC (MRK): Free Stock Analysis
PEPSICO INC (PEP): Free Stock Analysis Report
PROCTER & GAMBL (PG): Free Stock Analysis
TRANSOCEAN LTD (RIG): Free Stock Analysis
VIROPHARMA (VPHM): Free Stock Analysis Report
To read this article on Zacks.com click here.